Safety/Quality

Latest Issue of OR Manager
October 2024
Home Safety/Quality

FDA: Class I recall of certain SD BioSensor Pilot COVID-19 At-Home Tests

Editor's Note The Food and Drug Administration (FDA), on May 25, identified the recall by SD BioSensor, Inc, of certain Pilot COVID-19 At-Home Tests as Class I, the most serious. The recall was initiated because the liquid solution in the test kit may be contaminated with bacteria such as Enterococcus,…

Read More

By: Judy Mathias
May 30, 2023
Share

Value assessment of a trauma hybrid OR

Editor's Note This study from the University of Florida Health, Gainesville, examines the complications, cost-utility, and value of a dedicated trauma-endovascular hybrid OR. A total of 292 trauma patients, who underwent immediate operative intervention at a Level I trauma center (106 before construction of a hybrid OR and 186 after…

Read More

By: Judy Mathias
May 26, 2023
Share

SHEA: Strategies to prevent SSIs updated

Editor's Note The Society for Healthcare Epidemiology of America (SHEA) has updated the Strategies to Prevent Surgical Site Infection in Acute Care Hospitals, which was published in 2014. The update highlights practical recommendations designed to assist acute-care hospitals in implementing and prioritizing their surgical site infection (SSI) prevention efforts. Among…

Read More

By: Judy Mathias
May 26, 2023
Share

FDA: Class I recall of Draeger Medical’s Seattle PAP Plus, breathing circuit/anesthesia kits

Editor's Note The Food and Drug Administration (FDA), on May 24, identified the recall by Draeger Medical of the Seattle PAP Plus as well as VentStar and other breathing circuit/anesthesia kits as Class I, the most serious. The recall was initiated after finding that glued connections may loosen before or…

Read More

By: Judy Mathias
May 26, 2023
Share

Sponsored Message

Development of a definition for long COVID

Editor's Note This multi-center study, which is part of the National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) initiative and led by the Massachusetts General Hospital, Boston, was conducted to develop a definition of long COVID using self-reported symptoms of 9,764 participants (8,646 infected; 1,118 uninfected) at 85…

Read More

By: Judy Mathias
May 25, 2023
Share

The Joint Commission seeking comments on proposed new infection control requirements for hospitals, critical access hospitals

Editor's Note The Joint Commission, on May 24, announced that it is seeking comments on new infection control (IC) requirements for hospitals and critical access hospitals on preparedness for high-consequence diseases or special pathogens. These new requirements will replace the current standard IC.01.06.01 on preparing for an influx of potentially…

Read More

By: Judy Mathias
May 25, 2023
Share

Sponsored Message

Using human-AI collaboration to monitor PPE donning, doffing

Editor's Note This Australian study compares the accuracy of monitoring personal protective equipment (PPE) donning and doffing between an artificial intelligent (AI) machine collaborating with a remote buddy support system and an onsite buddy. The researchers conducted a pilot simulation study with 30 procedural scenarios (15 donning and 15 doffing)…

Read More

By: Judy Mathias
May 25, 2023
Share

Factors linked to protection from Omicron in vaccinated HCWs

Editor's Note This Israeli study finds that antibody levels were associated with protection against infection with the COVID-19 Omicron variant in vaccinated healthcare workers (HCWs). Participants included 2,310 HCWs who had received 3 or 4 doses of an mRNA COVID-19 vaccine. The odds of infection and substantial symptomatic disease caused…

Read More

By: Judy Mathias
May 24, 2023
Share

WHO launches International Pathogen Surveillance Network

Editor's Note The World Health Organization (WHO) and its partners, on May 20, launched the International Pathogen Surveillance Network (IPSN) to prevent and detect infectious disease threats before they become epidemics or pandemics. The network provides a platform for helping countries and regions improve systems for collecting and analyzing samples,…

Read More

By: Judy Mathias
May 24, 2023
Share

FDA: Class I recall of certain ICU Medical infusion system batteries

Editor's Note The Food and Drug Administration (FDA), on May 22, identified the recall by ICU Medical of replacement batteries for its Plum 360, Plum A+, and Plum A+3 infusions systems as Class I, the most serious. The recall was initiated because a manufacturing defect substantially diminished how long the…

Read More

By: Judy Mathias
May 23, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat